The brokerage cites reduced visibility into QDEL earnings as the reason for lowering its rating on the diagnostics firm.
Jefferies lowered its rating on QuidelOrtho (QDEL) to hold from buy, citing concerns over earnings visibility. The downgrade reflects uncertainty around the company’s near-term financial performance amid market challenges.
QuidelOrtho, a diagnostics and healthcare products firm, has faced volatility in recent quarters. Analysts had previously expected stable growth, but visibility into future earnings has diminished, prompting the rating cut.
Shares of QDEL showed minimal reaction in pre-market trading, as investors await further clarity on the company’s outlook.